Blackhawk Growth To Acquire Mycology Supplier Blum Distributors
The investment holding company Blackhawk Group (CSE:BLR) announced that it has entered into an all-stock purchase agreement with…
Core One Labs Begins Trading On OTCQB
Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB:CLABF) started trading on the OTCQB Venture Market. The…
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE:CYBN) CEO, Doug Drysdale has certainly…
Entheon Biomedical Announces Non-Brokered Private Placement Financing
Entheon Biomedical Corp. (OTCQB:ENTBF) announced a non-brokered private placement financing for up to 30,000,000 Units at a price of CDN$0.10…
MindMed Appoints Francois Lilienthal As New CCO
With over twenty years of experience in the biopharmaceutical industry, Francois Lilienthal, MD, has joined Mind Medicine Inc.…
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
With over ten years of experience in the pharmaceutical industry, Robert Barrow, CEO of Mind Medicine Inc. (NASDAQ:MNMD)…
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine’s Effects On The Brain
The first study visit to measure the psychedelic effects of ketamine in the cerebral cortex blood flow is underway, announced Cybin…
Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS
Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the…